查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球医疗器械外包市场
市场调查报告书
商品编码
1153823

2022-2029 年全球医疗器械外包市场

Global Medical Device Outsourcing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计2022年全球医疗器械外包市场规模将达到1125.7891亿美元，2029年将达到2897.6864亿美元，预测期内（2022-2029年）的复合年增长率为13.26%，有望继续增长。

外包是指公司要求第三方执行服务或创建产品，通常是为了降低成本。医疗器械行业将医疗器械的製造和相关服务外包。外包使设备製造商能够更快地将新产品推向市场并更快地获得投资回报。

市场动态

推动全球医疗器械外包市场的主要因素是心血管疾病等慢性病发病率上升、製造设施数量增加、运营成本降低以及外包需求增加。

扩大製造设施和降低运营成本预计将推动市场增长。

医疗设备外包市场受到对先进产品和离岸外包趋势不断增长的需求的推动。这种增长将主要受到医疗设备成本上升的推动，进而需要抑制不断增长的医疗保健支出。医疗设备製造商面临着降低管理费用和运营成本同时保持医疗服务质量的压力，这推动了医疗设备外包市场的发展。产品外包可以帮助降低 10-15% 的生产成本。

此外，对优质医疗保健的需求不断上升也是推动全球医疗器械外包市场增长的关键因素之一。所提供的医疗保健质量取决于诊断设备的质量。这迫使医疗设备製造商将产品开发外包，以在竞争激烈的医疗保健行业中获得优势。

医疗设备外包市场的另一个驱动因素是各种新产品发布和设施扩建。例如，2022 年 8 月，合同研究、开发和製造组织 (CRDMO) WuXi STA 宣布在美国特拉华州开设製药製造园区。将在美国建立第二家工厂以满足客户需求。

机密信息丢失的威胁预计会阻碍市场增长。

但是，在与第三方签订製造、产品设计、原型製作等合同时丢失敏感信息的风险正在阻碍全球医疗设备外包市场。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了积极影响。 COVID-19 的爆发严重影响了医疗保健行业。由于对新颖有效的疫苗和药物的需求增加以及临床试验数量的增加，医疗器械外包市场经历了巨大的增长。各种生物製药公司已与合同研究组织合作或合作，以满足需求和不断增长的研发活动。世界各地正在发生各种倡议、合作和合併，促进了市场的增长。例如，2022 年 7 月，Medidata 宣布扩大和更新与 Novotech 的合作伙伴关係，以继续在不同治疗领域进行临床研究。利用一系列技术，包括 Medidata 的 Rave EDC、Ecoa 和 Rave RTSM，Novotec 现在拥有可配置和灵活的功能来满足大规模临床研究需求的工具。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 降低生产成本
      • 扩大製造基地
    • 约束因素
      • 机密信息洩露的威胁
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章副产品

  • 原材料
  • 电子产品
  • 成品

第 8 章按设备类型

  • 一级
  • 二级
  • 三级

第9章服务

  • 设备製造委託
  • 原型开发
  • 临床研究和监管支持服务
  • 产品设计和开发
  • 产品测试
  • 组装和包装
  • 质量保证
  • 其他

第 10 章应用

  • 心脏病学
  • 骨科/脊柱
  • 放射科
  • 给药
  • 眼科
  • 通用医疗设备
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第13章公司简介

  • Integer Holdings Corporation
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Thermo Fisher Scientific
  • Nortech Systems, Inc.
  • Plexus Corp.
  • West Pharmaceutical Services, Inc
  • Celestica, Inc
  • Intertek Group
  • Wuxi Apptec
  • IQVIA Holdings
  • Benchmark Electronic Inc.

第14章 全球医疗器械外包市场-DataM

简介目录
Product Code: DMMD1185

Market Overview

The global medical device outsourcing market size was valued at US$ 112,578.91 million in 2022 and is estimated to reach US$ 289,768.64 million by 2029, growing at a CAGR of 13.26% during the forecast period (2022-2029).

Outsourcing is a practice usually undertaken by companies as a cost-cutting measure by hiring a party outside a company to perform services and create goods. The medical device industry is outsourcing both the manufacturing of medical devices and associated services; outsourcing can help equipment manufacturers to accelerate their time to market for a new product and speed up return on investment.

Market Dynamics

The major factors driving the global medical device outsourcing market are the rising incidence of chronic diseases such as cardiovascular, the increasing number of manufacturing facilities, reducing operational costs and the rising demand for outsourcing.

Expanding manufacturing facilities and reducing operational costs are expected to drive the market's growth.

The medical device outsourcing market is driven by rising demand for advanced products and the trend of offshoring. This growth would be mainly led by the need to curb the rising cost of medical equipment and, thereby, healthcare expenses. An increase in pressure on the manufacturers to reduce the overhead expenses and operational costs while maintaining the quality of healthcare services is propelling the medical device outsourcing market. Product outsourcing helps in reducing production costs by 10-15%.

Additionally, the growing demand for quality healthcare is one of the key factors driving the global medical devices outsourcing market growth. The quality of healthcare delivered depends on the quality of diagnostic devices. This forces device manufacturers to outsource product development to stay ahead in the competitive healthcare industry.

Another driving factor for the medical device outsourcing market is various novel product launches and facility expansion. For instance, in Aug 2022, WuXi STA, a contract research development and manufacturing organization (CRDMO), announced its pharmaceutical manufacturing campus in Delaware, United States. A second facility in the United States to meet the demand of customers.

The threat of losing confidential information is expected to hamper the market growth.

However, the threat of losing confidential information in contracting with a third party for manufacturing, product designing, prototyping, and others is hampering the global medical device outsourcing market.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The medical device outsourcing market has experienced huge profits due to the increase in demand for novel and effective vaccines and drugs and the rise in the number of clinical trials. Various biopharmaceutical companies partnered or collaborated with contract research organizations to meet the demands and growing R&D activities. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2022, Medidata announced their partnership expansion and renewal with Novotech to continue clinical studies in different therapeutic areas. Leveraging various technologies such as Rave EDC, Ecoa, Rave RTSM etc., from Medidata, Novotech now has equipped tools that are configurable and flexible and address clinical research needs at a large scale.

Segment Analysis

The services segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The services segment is the highest market holder in the global medical device outsourcing market. Based on the services segment, the contract device manufacturing sub-segment holds the largest market share. The need for contract manufacturing is increasing with the need for reducing operational costs and overhead expenses with good quality services.

Manufacturers require high-quality safety gadgets, and the rising manufacturing complexity makes contract manufacturing a better choice. Furthermore, during medical device development, inspection level is getting high, resulting in multiple standards and regulations, leading to increased demand for contract device manufacturing.

The service segment dominates the market due to the rising demand for contract manufacturing and rising global incidences of chronic diseases such as cardiovascular and neurological disorders. The growing number of regulatory approvals, technological advancements, expansion, and research/clinical trial studies drive the market's growth. For instance, in Aug 2022, Plexus Corp., a product design, manufacturing and marketing services provider, announced its novel manufacturing facility opening in Bangkok, Thailand. Around $60 million is invested in constructing a 400,000 sq. ft. site. This facility will strengthen energy-efficient operational and monitoring systems supporting Plexus's environmental, social and governance mission (ESG) for the betterment of the world.

Geographical Analysis

North America holds the largest market share in the global medical device outsourcing market.

North America dominates the global medical device outsourcing market, primarily attributed to the rising number of chronic disorders, such as cardiac and neurological. According to WHO, it was estimated that coronary artery disease (CAD) was responsible for a total of 11.1 million deaths globally in 2020.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. The presence of a large number of medical device manufacturers and the availability of advanced healthcare systems and manufacturing hubs for high-end, consistent, and complex medical devices in this region are contributing to the growth of the medical device outsourcing market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Apr 2022, Integer Holdings Corporation acquired Connemara Biomedical Holdings Teoranta along with its subsidiaries (Aran Biomedical & Proxy Biomedical). Aran is a high-precision biomaterial coating and advanced metal and polymer manufacturer for and provides solutions for implantable medical devices developing and manufacturing.

Competitive Landscape

The medical device outsourcing market is moderately competitive with local and global companies' presence. Integer Holdings Corporation, Thermo Fisher Scientific, Nortech Systems, Inc., Plexus Corp., West Pharmaceutical Services, Inc, Celestica, Inc, Intertek Group, Wuxi Apptec, IQVIA Holdings, Benchmark Electronic Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Apr 2021, IQVIA Holdings Inc., technology solutions, analytical and clinical research service provider, announced that it completely acquired Q2 Solutions, a clinical laboratory services organization, from Quest Diagnostics, a diagnostic information service provider. It already acquired 60% of the shares and now has acquired the remaining 40% of the minority shares resulting in 100% IQVIA's ownership.

Integer Holdings Corporation.

Overview: Integer Holdings is a medical device outsourcing company that serves various markets, such as cardiac, vascular, neuromodulation and portable medical markets. It provides a novel, innovative technologies with high quality to the medical device industry. It was established in 1940 and is headquartered in Texas, United States.

Product Portfolio:

QHR high-rate primary cells: These are commonly used for treating tachycardia in cardiac rhythm devices and for giving effective therapy in other implantable applications that need pulse currents of ampere-level. This QHR hybrid cathode technology is specially designed to provide high device performance and longevity in a small size.

Key Development: In Dec 2021, Integer Holdings Corporation, a manufacturer of medical device outsourcing, announced that it had completely acquired Oscor, Inc., a private company designing, developing and producing a portfolio of highly specific implantable devices, medical devices, and diagnostic catheters.

The global medical device outsourcing market report would provide access to approx. 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Reducing production cost
      • 4.1.1.2. Expansion of manufacturing facilities
    • 4.1.2. Restraints:
      • 4.1.2.1. Threat of loss of confidential information
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Raw Material *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Electronics
  • 7.4. Finished Goods

8. By Device Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 8.1.2. Market Attractiveness Index, By Device Type
  • 8.2. Class I *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Class II
  • 8.4. Class III

9. By Services

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 9.1.2. Market Attractiveness Index, By Services
  • 9.2. Contract Device Manufacturing *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Prototype Development
  • 9.4. Clinic Research & Regulatory Support Services
  • 9.5. Product Design and Development
  • 9.6. Product Testing
  • 9.7. Assembly & Packaging
  • 9.8. Quality Assurance
  • 9.9. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Cardiovascular *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Orthopedic & Spine
  • 10.4. Radiology
  • 10.5. Drug Delivery
  • 10.6. Ophthalmic
  • 10.7. General Medical Devices
  • 10.8. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Integer Holdings Corporation
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Thermo Fisher Scientific
  • 13.3. Nortech Systems, Inc.
  • 13.4. Plexus Corp.
  • 13.5. West Pharmaceutical Services, Inc
  • 13.6. Celestica, Inc
  • 13.7. Intertek Group
  • 13.8. Wuxi Apptec
  • 13.9. IQVIA Holdings
  • 13.10. Benchmark Electronic Inc.

LIST NOT EXHAUSTIVE

14. Global Medical Device Outsourcing Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us